Highly Retina-Permeating and Long-Acting Resveratrol/Metformin Nanotherapeutics for Enhanced Treatment of Macular Degeneration.
ACS Nano
; 17(1): 168-183, 2023 01 10.
Article
in En
| MEDLINE
| ID: mdl-36524981
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Retinal Diseases
/
Nanoparticles
/
Macular Degeneration
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
ACS Nano
Year:
2023
Document type:
Article
Affiliation country:
Taiwán
Country of publication:
Estados Unidos